Peplin Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $288M

Peplin General Information

Description

Developer of medical dermatology products. The comapny offers PEP005, a compound derived from euphorbia peplus used for various conditions, including topical self-treatment of various skin disorders, such as melanoma and non-melanoma skin cancer, as well as pre-cancerous skin lesions/actinic keratosis.

Contact Information

Website
www.peplin.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6475 Christie Avenue
  • Suite 300
  • Emeryville, CA 94608
  • United States
+1 (510)
Primary Industry
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 6475 Christie Avenue
  • Suite 300
  • Emeryville, CA 94608
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Peplin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 12-Nov-2009 $288M Completed Generating Revenue
3. PIPE 23-Oct-2008 Completed Generating Revenue
2. Convertible Debt 30-Jan-2008 $900K $900K Completed Generating Revenue
1. IPO 22-Sep-2000 Completed Generating Revenue
To view Peplin’s complete valuation and funding history, request access »

Peplin Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Peplin Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Acorn Capital Growth/Expansion Minority
Allan Gray Australia Mutual Fund Minority
Burrill & Co Merchant Banking Firm Minority
Construction and Building Unions Superannuation Limited Partner Minority
GBS Venture Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Peplin Acquisitions (1)

Peplin’s most recent deal was a Merger/Acquisition with Neosil for . The deal was made on 20-Oct-2008.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Neosil 20-Oct-2008 Merger/Acquisition Pharmaceuticals
To view Peplin’s complete acquisitions history, request access »

Peplin FAQs

  • When was Peplin founded?

    Peplin was founded in 1998.

  • Where is Peplin headquartered?

    Peplin is headquartered in Emeryville, CA.

  • What is the size of Peplin?

    Peplin has 7 total employees.

  • What industry is Peplin in?

    Peplin’s primary industry is Drug Discovery.

  • Is Peplin a private or public company?

    Peplin is a Private company.

  • What is the current valuation of Peplin?

    The current valuation of Peplin is .

  • What is Peplin’s current revenue?

    The current revenue for Peplin is .

  • How much funding has Peplin raised over time?

    Peplin has raised $24.9M.

  • Who are Peplin’s investors?

    Acorn Capital, Allan Gray Australia, Burrill & Co, Construction and Building Unions Superannuation, and GBS Venture Partners are 5 of 7 investors who have invested in Peplin.

  • When was Peplin acquired?

    Peplin was acquired on 12-Nov-2009.

  • Who acquired Peplin?

    Peplin was acquired by LEO Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process